BDBM100791 US8507533, 31

SMILES CCCCc1ccn(n1)-c1ccc(OC(CCC)c2ccc(cc2)C(=O)NCCC(O)=O)cc1

InChI Key InChIKey=ZSFWLJDUORSGEN-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 100791   

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM100791(US8507533, 31)
Affinity DataKi:  1.33E+3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent